These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9859148)

  • 1. [Oral anticoagulation in the secondary prevention of cerebrovascular disease. Long-term follow-up of 169 patients].
    Palomeras E; Roquer J; Pou A
    Rev Neurol; 1998 Nov; 27(159):772-6. PubMed ID: 9859148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemorrhagic complications from anticoagulant treatment: analysis of predictive risk factors].
    Vázquez Ruiz de Castroviejo E; del Monte Trujillo Pérez M; Lozano Cabezas C; Avellaneda Molina C; Guzmán Herrera M; Martínez Galiano E; Pousibet Sanfeliú H; Tarabini Castellani A; Pagola Vilardebó C; Alcalá Muñoz A
    Sangre (Barc); 1999 Jun; 44(3):216-21. PubMed ID: 10481584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
    Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
    Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late incidence and determinants of stroke after aortic and mitral valve replacement.
    Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
    Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
    J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
    Pengo V; Legnani C; Noventa F; Palareti G;
    Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk of chronic oral anticoagulant treatment in elderly patients].
    Braun S; Chamorro G; Wilson C; Casanegra P; Corbalán R; Iirarrázaval MJ; Kobus C; Valle I
    Rev Med Chil; 1992 May; 120(5):552-8. PubMed ID: 1343069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
    Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention of cerebral embolism of cardiac origin].
    Mas JL
    J Mal Vasc; 1993; 18(4):283-92. PubMed ID: 8120458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2005 Sep; 18(9):919-24. PubMed ID: 16153514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.
    Nowacki P; Porebska A; Bajer-Czajkowska A; Zywica A; Koziarska D; Podbielski J
    Ann Acad Med Stetin; 2007; 53(2):14-9. PubMed ID: 18557372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis].
    Alonso Martínez JL; Abínzano Guillén ML; Urbieta Echezarreta MA; Annichérico Sánchez FJ; Fernández Ladrón V; García Sanchotena JL
    An Med Interna; 2008 Jan; 25(1):4-8. PubMed ID: 18377187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Left coronary artery embolism resulting from ineffective anticoagulation in a patient suffering from dilated cardiomyopathy as a possible cause of myocardial infarction--a case report].
    Krzyzak P; Szymczyk R; Janion M; Tomaszewski P
    Kardiol Pol; 2007 Jun; 65(6):698-701; discussion 701-2. PubMed ID: 17629833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy].
    Strach K; Meyer C; Hackenbroch M; Tiemann K; Haase J; Pizulli L; Omran H; Schild H; Sommer T
    Rofo; 2005 Dec; 177(12):1706-12. PubMed ID: 16333795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term results of prosthetic mitral valve replacement with home-made tilting disc valve: a report of 125 cases].
    Zhang BR; Xu ZY; Zou LJ; Mei J; Wang ZN; Hao JH
    Zhonghua Wai Ke Za Zhi; 2003 Apr; 41(4):253-6. PubMed ID: 12882665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.